Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10

Literature DB >> 27696038

J C Rageth¹, L Bronz², S Granberg³.

Abstract

Year: 1995 PMID： 27696038 DOI： 10.1007/BF02201946

Source DB: PubMed Journal: Arch Gynecol Obstet ISSN： 0932-0067 Impact factor: 2.344

Keyword Cloud
References

× No keyword cloud information.

21 in total

1. Endometrial lesions in patients undergoing tamoxifen therapy.

Authors: X De Muylder; P Neven; M De Somer; Y Van Belle; G Vanderick; E De Muylder
Journal: Int J Gynaecol Obstet Date: 1991-10 Impact factor: 3.561

2. Tamoxifen and the uterus.

Authors: P Neven; X De Muylder; Y Van Belle; R Campo; G Vanderick
Journal: BMJ Date: 1994-11-19

3. Lack of induction of endometrial hyperplasia with tamoxifen.

Authors: P Touraine; P Driguez; I Cartier; H Yaneva; F Kuttenn; P Mauvais-Jarvis
Journal: Lancet Date: 1995-01-28 Impact factor: 79.321

4. [Postmenopausal hemorrhage and endometrial cancer in tamoxifen therapy].

Authors: A Krause; B Gerber
Journal: Zentralbl Gynakol Date: 1994

5. Diagnostic pitfalls of ultrasonographic uterine screening in women treated with tamoxifen.

Authors: J Bornstein; R Auslender; B Pascal; E Gutterman; D Isakov; H Abramovici
Journal: J Reprod Med Date: 1994-09 Impact factor: 0.142

6. Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group.

Authors: L E Rutqvist; H Johansson; T Signomklao; U Johansson; T Fornander; N Wilking
Journal: J Natl Cancer Inst Date: 1995-05-03 Impact factor: 13.506

1. Endometrial lesions in patients undergoing tamoxifen therapy.

2. Tamoxifen and the uterus.

3. Lack of induction of endometrial hyperplasia with tamoxifen.

4. [Postmenopausal hemorrhage and endometrial cancer in tamoxifen therapy].

5. Diagnostic pitfalls of ultrasonographic uterine screening in women treated with tamoxifen.

6. Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group.

7. Asymptomatic carcinoma of the endometrium in a patient on adjunctive tamoxifen therapy for carcinoma of the breast.

8. Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer.

Review 9. What do we know and what don't we know about tamoxifen in the human uterus.

10. Risk of endometrial cancer after tamoxifen treatment of breast cancer.